Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists
Journal of Molecular Neuroscience · 15.10.2025 · 75 (4)
DOI: 10.1007/s12031-025-02433-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 15.10.2025. Verfasst von Sharanappa Gurikar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Mandya, Karnata…. Hauptthemen laut MEDLINE: Alzheimer Disease, Oligodendroglia, Drug Repositioning, Serotonin Receptor Agonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 162 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Mandya, Karnataka, India, 571448.
- Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Mandya, Karnataka, India, 571448. sagheer@accp.co.in.
Zitieren
APA
Gurikar, S., Ahmed, S. S., & Raghunatahanaidu, B. D. (2025). Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists. Journal of Molecular Neuroscience, 75(4). https://doi.org/10.1007/s12031-025-02433-5
Vancouver
Gurikar S, Ahmed SS, Raghunatahanaidu BD. Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists. Journal of Molecular Neuroscience. 2025;75(4). doi:10.1007/s12031-025-02433-5
BibTeX
@article{Gurikar2025,
author = {Gurikar, Sharanappa and Ahmed, Syed Sagheer and Raghunatahanaidu, Bharathi Doddlu},
title = {Targeting Oligodendrocyte Dysfunction in Alzheimer’s Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists},
journal = {Journal of Molecular Neuroscience},
year = {2025},
volume = {75},
number = {4},
doi = {10.1007/s12031-025-02433-5}
}
EUVIMED